FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386843669> ?p ?o ?g. }

• W4386843669 endingPage "1049" @default.
• W4386843669 startingPage "1039" @default.
• W4386843669 abstract "Tumor markers have been widely used clinically. Detection of serum CA125 is one of the commonly used clinical methods for early screening and early diagnosis of epithelial ovarian cancer, but it is difficult to diagnose epithelial ovarian cancer with a single specific tumor marker. In this study, the combinatorial tumor marker detection method was used to compare the value of each tumor marker alone and different combinations in the diagnosis of epithelial ovarian cancer.The clinical data of patients with epithelial ovarian cancer (n=65) and ovarian benign disease (n=29) were collected. Multiple tumor marker protein chip was used to detect cancer antigen 125 (CA125), carbohydrate antigen 242 (CA242), alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (β-HCG), carcinoembryonic antigen (CEA), cancer antigen 199 (CA199), neuron-specific enolase (NSE), Ferritin, cancer antigen 153 (CA153), and human growth hormone (HGH) serum levels, and to compare the differences between the benign and malignant ovarian tumors. The correlation between tumor markers and clinicopathologic features for ovarian epithelial carcinoma was analyzed by χ2 test. Spearman rank analysis showed the correlation between CA125 expression level and other tumor markers in epithelial ovarian cancer and the correlation between age and the above 10 tumor markers. Sensitivity, specificity, positive predictive value, negative predictive value, Youden index, and diagnostic efficiency were used to evaluate the diagnostic value of single tumor marker and the combination of tumor markers.The levels of β-HCG, NSE, CA153, and CA125 in the epithelial ovarian cancer group were higher than those in the ovarian benign disease group. The level of NSE in the serum of patients with epithelial ovarian cancer was related to the clinical stage of patients. In addition, the levels of CA242, β-HCG, CEA, NSE, Ferritin, CA153 in the serum of patients with epithelial ovarian cancer were positively correlated with CA125 (rs=0.497, P<0.001; rs=0.612, P<0.001; rs=0.358, P=0.003; rs=0.680, P<0.001; rs=0.322, P=0.009; rs=0.609, P<0.001, respectively), and the levels of β-HCG, Ferritin, CA153 were positively correlated with the patient's age (rs=0.256, P=0.040; rs=0.325, P=0.008; rs=0.249, P=0.046, respectively). In the diagnosis of epithelial ovarian cancer, the sensitivity, Youden index, and diagnostic efficiency of CA125 detection alone were higher than the results of the other 9 separate detections. When CA153, CA199, CA242, Ferritin, and CEA were combined with CA125, the sensitivity of the combined detection of different combinations was higher than that of CA125 alone. The combined detection sensitivities of CA125+CEA and CA125+Ferritin+CEA were 89.2% and 90.8%, respectively, and the diagnostic efficiencies were both 84.1%, which were higher than those of other combinations. The Youden index of CA125+CEA joint detection was 0.616, which was higher than those of other combinations.CA125 has a high diagnostic value in the diagnosis of epithelial ovarian cancer. The detection of combined tumor markers in serum has higher sensitivity and specificity in epithelial ovarian cancer.目的: 肿瘤标志物已广泛应用于临床。血清CA125检测是目前临床常用的上皮卵巢癌早期筛查和早期诊断方法之一，但使用单一特异性肿瘤标志物诊断上皮性卵巢癌比较困难。本研究采用肿瘤标志物组合检测法，比较各肿瘤标志物单独检测与联合检测在上皮性卵巢癌诊断中的价值。方法: 收集上皮性卵巢癌患者(n=65)和卵巢良性疾病患者(n=29)的临床资料。采用多肿瘤标志物蛋白质芯片检测癌抗原125(cancer antigen 125，CA125)、糖类抗原242(carbohydrate antigen 242，CA242)、甲胎蛋白(alpha-fetoprotein，AFP)、β-人绒毛膜促性腺激素(beta-human chorionic gonadotropin，β-HCG)、癌胚抗原(carcinoembryonic antigen，CEA)、癌抗原199(cancer antigen 199，CA1990)、神经元-特性烯醇化酶(neuron-specific enolase，NSE)、铁蛋白(Ferritin)、癌抗原153(cancer antigen 153，CA153)以及人生长激素(human growth hormone，HGH)的血清水平，比较其在卵巢良恶性肿瘤中的差异；χ2检验分析肿瘤标志物与卵巢上皮癌患者临床病理特征的相关性；Spearman秩关性分析上皮性卵巢癌CA125与其他肿瘤标志物表达水平及年龄与上述10种肿瘤标志物的相关性；采用灵敏度、特异度、阳性预测值、阴性预测值、约登指数及诊断效率分别评价各肿瘤标志物单项检测及联合检测的诊断价值。结果: 上皮性卵巢癌组中的β-HCG、NSE、CA153和CA125水平均高于卵巢良性疾病组。上皮性卵巢癌患者血清中NSE的水平与患者的临床分期相关。此外，上皮性卵巢癌患者血清中CA242、β-HCG、CEA、NSE、Ferritin、CA153水平与CA125水平呈正相关(分别rs=0.497、P<0.001；rs=0.612、P<0.001；rs=0.358、P=0.003；rs=0.680、P<0.001；rs=0.322、P=0.009；rs=0.609、P<0.001)， β-HCG、Ferritin、CA153水平与患者年龄呈正相关(分别rs=0.256、P=0.040；rs=0.325、P=0.008；rs=0.249、P=0.046)。在上皮性卵巢癌诊断中，CA125单独检测的灵敏度、约登指数及诊断效率均高于其他9种肿瘤标志物单独检测的结果；CA153、CA199、CA242、Ferritin、CEA与CA125进行联合检测时，其灵敏度均高于CA125单独检测的灵敏度，其中CA125+CEA、CA125+Ferritin+CEA这2种组合的灵敏度分别为89.2%和90.8%，诊断效率均为84.1%，高于其他组合的诊断效率。CA125+CEA联合检测时其约登指数为0.616，高于其他组合。结论: CA125在诊断上皮性卵巢癌方面具有较高的诊断价值。血清中的肿瘤标志物组合检测在上皮性卵巢癌中具有更高的灵敏度和特异度。." @default.
• W4386843669 created "2023-09-20" @default.
• W4386843669 creator A5034180926 @default.
• W4386843669 creator A5051102943 @default.
• W4386843669 creator A5063097409 @default.
• W4386843669 creator A5075569191 @default.
• W4386843669 date "2023-07-28" @default.
• W4386843669 modified "2023-09-27" @default.
• W4386843669 title "Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer." @default.
• W4386843669 doi "https://doi.org/10.11817/j.issn.1672-7347.2023.230090" @default.
• W4386843669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37724407" @default.
• W4386843669 hasPublicationYear "2023" @default.
• W4386843669 type Work @default.
• W4386843669 citedByCount "0" @default.
• W4386843669 crossrefType "journal-article" @default.
• W4386843669 hasAuthorship W4386843669A5034180926 @default.
• W4386843669 hasAuthorship W4386843669A5051102943 @default.
• W4386843669 hasAuthorship W4386843669A5063097409 @default.
• W4386843669 hasAuthorship W4386843669A5075569191 @default.
• W4386843669 hasConcept C111683008 @default.
• W4386843669 hasConcept C118646709 @default.
• W4386843669 hasConcept C121608353 @default.
• W4386843669 hasConcept C126322002 @default.
• W4386843669 hasConcept C142724271 @default.
• W4386843669 hasConcept C143998085 @default.
• W4386843669 hasConcept C2777387746 @default.
• W4386843669 hasConcept C2780084626 @default.
• W4386843669 hasConcept C2780427987 @default.
• W4386843669 hasConcept C2781447364 @default.
• W4386843669 hasConcept C530470458 @default.
• W4386843669 hasConcept C71924100 @default.
• W4386843669 hasConceptScore W4386843669C111683008 @default.
• W4386843669 hasConceptScore W4386843669C118646709 @default.
• W4386843669 hasConceptScore W4386843669C121608353 @default.
• W4386843669 hasConceptScore W4386843669C126322002 @default.
• W4386843669 hasConceptScore W4386843669C142724271 @default.
• W4386843669 hasConceptScore W4386843669C143998085 @default.
• W4386843669 hasConceptScore W4386843669C2777387746 @default.
• W4386843669 hasConceptScore W4386843669C2780084626 @default.
• W4386843669 hasConceptScore W4386843669C2780427987 @default.
• W4386843669 hasConceptScore W4386843669C2781447364 @default.
• W4386843669 hasConceptScore W4386843669C530470458 @default.
• W4386843669 hasConceptScore W4386843669C71924100 @default.
• W4386843669 hasIssue "7" @default.
• W4386843669 hasLocation W43868436691 @default.
• W4386843669 hasOpenAccess W4386843669 @default.
• W4386843669 hasPrimaryLocation W43868436691 @default.
• W4386843669 hasRelatedWork W2056998303 @default.
• W4386843669 hasRelatedWork W2104075936 @default.
• W4386843669 hasRelatedWork W2349019963 @default.
• W4386843669 hasRelatedWork W2357116174 @default.
• W4386843669 hasRelatedWork W2378679291 @default.
• W4386843669 hasRelatedWork W2526374665 @default.
• W4386843669 hasRelatedWork W2608202513 @default.
• W4386843669 hasRelatedWork W3120233813 @default.
• W4386843669 hasRelatedWork W33684711 @default.
• W4386843669 hasRelatedWork W4386843669 @default.
• W4386843669 hasVolume "48" @default.
• W4386843669 isParatext "false" @default.
• W4386843669 isRetracted "false" @default.
• W4386843669 workType "article" @default.